PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Polyether Polyketides”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 163 records · Page 9Linked to original sources

Salinomycin and lasalocid effects on growth rate, mineral metabolism and ruminal fermentation in steers.

Two experiments were conducted to determine the effects of salinomycin and lasalocid on metabolism and growth of growing steers. In Exp. 1, 80 Angus steers (228 kg) were assigned to the following treatments: 1) control, 2) 50 mg salinomycin.hd-1.d-1, 3) 100 mg salinomycin.hd-1.d-1 and 4) 250 mg lasalocid.hd-1.d-1. Steers were fed corn silage once daily with allotments based on the amount of silage that each pen of five steers would consume in a 24-h period. In addition, .81 kg/hd of a corn-soybean meal supplement was fed daily during the 112-d study. Daily gains were similar across treatments, but feed intake was lower (P less than .05) for steers fed ionophores. Molar proportions of ruminal acetate were lower (P less than .05) in steers fed ionophores at 28 and 90 d. Ruminal propionate was lower (P less than .05) in control steers at 28 d, but values were similar across treatments on d 90. Plasma copper (Cu) was lower (P less than .05) in control steers on both sampling days. In Exp. 2, 16 Hereford steers were allotted to two blocks of eight animals each and assigned to one of three treatments: 1) control (n = 6), 2) 11 mg salinomycin/kg diet (n = 6) and 3) 33 mg lasalocid/kg diet (n = 4). Following a 28-d adjustment period, apparent absorption and retention of macrominerals and nitrogen (N) were determined during a 5-d collection period. Apparent absorption and retention of N did not differ among treatments when data were analyzed using N intake as a covariate.(ABSTRACT TRUNCATED AT 250 WORDS)

Analysis of Variance↗

Efficacy of selected oral chemotherapeutants against Ichthyophthirius multifiliis (Ciliophora: Ophyroglenidae) infecting rainbow trout Oncorhynchus mykiss.

The chemotherapeutic efficacy of 6 in-feed compounds against Ichthyophthirius multifiliis Fouquet, 1876 was assessed using experimental infections of rainbow trout Oncorhynchus mykiss (Walbaum) fingerlings. Trial doses of 104 ppm amprolium hydrochloride or 65 ppm clopidol fed to fish for 10 d prior to infection significantly reduced the number of trophonts establishing in trout fingerlings by 62.0 and 35.2% respectively. In-feed treatments of infected trout with either 63 or 75 ppm amprolium hydrochloride, 92 ppm clopidol, or 38, 43 or 47 ppm salinomycin sodium for 10 d also significantly reduced the number of surviving trophonts by 77.6 and 32.2% for amprolium, 20.1% for clopidol and 80.2, 71.9 and 93.3% respectively for salinomycin sodium.

Administration, Oral↗

Efficacy and toxicity of orally administrated anti-coccidial drugs for innovative treatments of Myxobolus sp. infection in Puntazzo puntazzo.

This study tested drugs and therapeutic compounds to determine effective commercial treatment for fishes infected with myxosporeans. Two series of shore-based experiments and 1 field trial were performed. For the shore-based experiments we used Puntazzo puntazzo (ca. 20 g weight) with kidneys infected with Myxobolus sp. Initially, 6 different doses of Fumagillin, 2 doses of Toltrazuril, and 1 dose of Amprolium, ESB3 and Salinomycin were tested. In the second shore-based experiment, infected fish were treated with Origanum essential oils, Toltrazuril with propylene glycol, Amprolium, and a combination of Salinomycin 12% + Amprolium (SA). In the field trial, P. puntazzo (ca. 165 g) infected with the parasite were treated with SA, Origanum essential oils and Fumagillin. In all trials, the drugs were added to the feed and administered according to the selected regimen. Their efficacy was evaluated in terms of mortality (acceptable level was <3%), pathology and prevalence rate of Myxobolus sp. Lesions were observed only in fish treated with Fumagillin and Toltrazuril. Pathology due to treatment with Fumagillin was observed only at doses > 6 mg kg(-1) body wt for 6 wk in the interstitial renal tissue, where slight inflammation arose. The highest dose tested (25 mg kg(-1)) also produced necrosis in the interstitial tissue, degeneration of the epithelial cells of the tubules and a reduction in melanomacrophage centre numbers. The SA combination proved the most effective treatment for Myxobolus sp. infection of P. puntazzo as (1) the therapeutic regimen and commercial product was not toxic and (2) a significant reduction occurred in the prevalence rate.

Amprolium↗

[Effects of veterinary drugs on beta-hexosaminidase release from rat basophilic leukemia cells (RBL-2H3)].

Little is known about the effects of residual veterinary drugs on the allergic reaction, except for the antigenicity of antibiotics and synthetic antimicrobials. Therefore, 59 kinds of veterinary drugs were investigated for their effects on the IgE receptor-mediated beta-hexosaminidase release from RBL-2H3 cells as an index of immediate allergic reaction. We found that the antibiotics chlorotetracycline, doxycycline, monensin, the synthetic antimicrobial pyrimethamine and the steroid hormone testosterone inhibited beta-hexosaminidase release. Most of the veterinary drugs showed no action, though the ionophores lasalocid, salinomycin and the steroid hormone hexestrol promoted beta-hexosaminidase release from injured cells. Based on the residual levels of these drugs and the frequencies of detection in actual food samples, it seems unlikely that these drugs have any immediate allergic effect in practice.

Animals↗

[Inhibitory effect of zinc on beta-hexosaminidase release from RBL-2H3 cells by synthetic chemicals].

The effects of foods and chemicals related to food hygiene on degranulation were evaluated using a method for assaying the enzyme activity of beta-hexosaminidase as an index of chemical mediator release from RBL-2H3 cells in vitro. Using a previously developed assay system, we had found a large number of inhibitors and promoters of degranulation of RBL-2H3 cells. In the present study, we examined the inhibitory effect of zinc chloride on the degranulation (beta-hexosaminidase release) from RBL-2H3 cells with or without antigen in the presence of the degranulation-promotive chemicals, namely, 4 food additives, 7 pesticides and 2 veterinary drugs. These promotive chemicals were classified into two types on the basis of inhibitory profile by zinc chloride: 1) those which showed marked degranulation-inhibitory action when the cells were stimulated with antigen, such as butylhydroxyanisole, dibutylhydroxytoluene, EPN, cis- and trans-permethrin, prothiofos, pyridaben, terbufos, 2) those which showed marked degranulation-inhibitory action whether the cells were stimulated with antigen or not, such as butyl p-hydroxybenzoate, o-phenylphenol, bitertanol, salinomycin. In conclusion, zinc had a dramatic inhibitory effect on enhanced degranulation induced by synthetic chemicals in vitro.

Animals↗

Anticoccidial activity of salinomycin in battery raised broiler chickens.

Infections with single species of Eimeria acervulina, E. mivati, E. maxima, E. tenella, E. necatrix, and E. brunetti, and the six species mixed, were utilized in three separate battery experiments to evaluate the anticoccidial efficacy of various levels of salinomycin (AHR-3096), a fermentation product of a strain of Streptomyces albus. At the 60 to 100 p.p.m. treatment levels, this compound showed significant anticoccidial activity for all parameters studied (mortality, weight gain, feed conversion, dropping scores, and lesion scores). The mortality due to coccidiosis was reduced to 0.1% in the medicated infected birds. Some activity, as measured by weight gain, was seen in the lower levels of salinomycin medication (12.5 to 50 p.p.m.), but other parameters, including mortality and lesion scores, indicated less activity than that seen with the higher treatment levels. At 100 p.p.m., there was no apparent effect on the compound on bird performance in uninfected control birds. Salinomycin at the 100 p.p.m. treatment level was statistically as effective as 121 p.p.m. monensin (reference anticoccidial) in controlling coccidiosis.

Animal Feed↗

Anticoccidial activity of salinomycin in floor-pen experiments with broilers.

The anticoccidial agent salinomycin (AHR-3096) was compared at various treatment levels (60 to 100 p.p.m.) in two experiments against unmedicated and either 100 or 121 p.p.m. monensin-medicated groups to evaluate its performance under floor-pen conditions. Various methods for the initial rearing of birds and coccidial exposure were employed to test the efficacy of salinomycin against severe, moderate, and mild coccidiosis. Salinomycin at all treatment levels showed definite anticoccidial activity resulting in improved weights, feed conversion ratios, lesion scores, and mortality compared with unmedicated controls. In pens with severe coccidiosis, this compound demonstrated a significant improvement in all parameters when compared with the corresponding unmedicated controls. Salinomycin-treated pens exposed to light coccidiosis usually had a numerical increase in the parameters over the unmedicated control groups. Statistical analysis of overall main effects on mortality, weight gain, and feed conversion ratio showed no significant differences between the activity of any level of salinomycin and monensin.

Animal Feed↗

Safety evaluation of salinomycin in broiler chickens reared in floor pens.

Salinomycin (Coxistac), a new broad spectrum anticoccidial, was tested in broilers reared in floor pens for safety at 50, 60, 80, 100, and 160 ppm fed continuously from 1 to 56 days of age. Four trials were conducted. Comparisons were made to unmedicated controls and in three trials to monensin to monensin at 80, 100, and 121 ppm. The weight gains at 50 and 60 ppm of salinomycin and 80 and 100 ppm of monensin were statistically comparable and equivalent to or better than controls. The weight gain at 80 ppm of salinomycin was slightly below controls but comparable to 121 ppm monensin. Levels of 100 and 160 ppm of salinomycin depressed weight gain. Feed conversion for all treatments except 160 ppm salinomycin were comparable.

Animals↗

Efficacy of salinomycin and stenorol against various species of Eimeria and effect on chick performance.

Three experiments were designed to test the efficacy of salinomycin and stenorol against infection by various Eimeria species on cage reared broiler type chicks. Efficacy was based on a coccidial index. Sixty parts per million salinomycin alone or in combination with 50 ppm 3 nitro significantly improved the index over basal treatments or when 3 nitro was used alone. The differences in index values recorded for coban and salinomycin were not significant. Stenorol significantly improved the index and appeared to be a most effective anticoccidial product. Broiler chickens reared in floor pens to 8 weeks showed a significant reduction in weight gain when the diet contained salinomycin +3 nitro or coban. Stenorol at 3, 6, or 9 ppm reduced body weight, with linear regression for this effect being highly significant (P less than .01). No coccidiosis was observed.

Animals↗

Compensatory growth in broilers after withdrawal of ionophorous anticoccidial drugs.

Three polyether, ionophorous anticoccidial drugs were fed to broiler chickens in floor pens for 5 or 6 weeks, then withdrawn for 2 weeks or 1 week, respectively. With monensin and salinomycin there was evidence of increased feed consumption and compensatory growth during the first week, but not the second week, after drug withdrawal. There was no evidence of compensatory growth in birds fed lasalocid. Final weights were best in birds fed lasalocid and salinomycin in comparison with unmedicated controls and birds fed monensin. There was evidence of increased feed consumption and compensatory growth in some treatments in which birds weighed more than controls prior to drug withdrawal.

Animals↗

Evaluation of the efficacy of salinomycin in the control of coccidiosis in chicks.

Salinomycin (Coxistac) was tested for efficacy in broilers reared in floor pens at 60 and 80 ppm fed continuously from 1 to 56 days of age. One trial was conducted. Comparisons were made with unmedicated, infected and medicated, noninfected treatments (controls) in addition to infected treatments given either monensin at 100 ppm or halofuginone at 3 ppm continuously (days 1 to 56) in the feed. Coccidia exposure was obtained by infection via the feed. Salinomycin was highly efficacious at 60 ppm based upon improved performance, lesion score, hematocrit, and serum optical density compared with the unmedicated, infected group. Statistical analysis of main effects on weight gain, feed conversion ratio, hematocrit value, and serum optical density showed no significant differences between salinomycin, monensin, or halofuginone. The weight gain of birds given salinomycin at 80 ppm was depressed significantly (P less than .01) at 56 days as a result of decreased feed consumption.

Animals↗

Anticoccidial efficacy of salinomycin (AHR-3096C) and compatibility with roxarsone in floor-pen experiments with broilers.

Five experiments were conducted to test the anticoccidial efficacy of salinomycin (AHR-3096C, A. H. Robins) at 66 ppm and its compatibility with roxarsone (50 ppm) under floor pen conditions Monensin (100, 121 ppm), lasalocid (75, 125 ppm), and shuttle programs of salinomycin-monensin (66/100 ppm) or monensin-salinomycin (100/66 ppm) were included for comparison. Coccidiosis exposure was provided by using the infected seeder bird technique. Salinomycin reduced the lesion scores significantly and improved the body weight and feed conversion in all the trials as compared to unmedicated groups. All three ionophores effectively reduced the lesion scores. Birds treated with salinomycin-monensin shuttle programs had lesion scores, body weight, and feed conversion that were not significantly different from the salinomycin treated birds, suggesting that this shuttle program could be used satisfactorily for control of coccidiosis. Lesion scores, body weight, and feed conversion data of the 4th and 5th trials suggested that the anticoccidial activity of salinomycin and roxarsone are additive. There was evidence of compensatory growth after withdrawal of salinomycin and monensin but not with lasalocid.

Animals↗

Influence of salinomycin on incidence, shedding, and antimicrobial resistance of Salmonella typhimurium in experimentally infected broiler chicks.

Twenty broiler chickens were fed 80 g/T salinomycin, an antibiotic produced by Streptomyces albus, and 20 birds were fed a control, unmedicated feed. The birds were experimentally infected with Salmonella typhimurium. The study evaluated the effects of salinomycin on Salmonella incidence, shedding, and antimicrobial resistance. Salinomycin had no effect on body weights, length of time salmonellae were shed, number of salmonellae shed on postdosing day 3, salmonellae tissue recoverability, or on the total number of resistance patterns. Salinomycin caused the decline of salmonellae to be more gradual; however, both treatments were comparable at the end of the study. The majority of isolated from birds receiving salinomycin maintained the original S. typhimurium antibiogram of streptomycin, sulfadiazine, and nalidixic acid. The salinomycin salmonellae were more susceptible to tetracycline, amikacin, carbenicillin, gentamicin, and cephalothin. The multiple resistance patterns of eight and nine drugs tended to be more prevalent among salmonellae from control birds than salinomycin treated birds. The antibiotic salinomycin appears to be an acceptable feed additive in broilers at the level of 80 g/T based on these results of its effects on salmonellae shedding and antimicrobial resistance.

Animals↗

Influence of salinomycin on antimicrobial resistance of coliforms and streptococci from broiler chickens.

An experiment was conducted to evaluate antimicrobial resistance of coliforms and streptococci isolated from feces of chickens fed salinomycin. Two groups of 20 chickens were fed either a control feed or feed supplemented with 80 g/ton salinomycin. Chicken fecal coliforms and streptococci were isolated at 5, 15, 19, 22, 26, 33, 40, and 47 days of age and their resistance to 11 or 12 antibacterial agents (coliforms and streptococci, respectively) were determined in both groups of chickens. Salinomycin significantly reduced the number of coliforms resistant to sulfadiazine and reduced the number of streptococci resistant to erythromycin and lincomycin. Streptococci from birds fed salinomycin had lower minimum inhibitory concentrations for streptomycin. No streptococci isolates developed resistance to salinomycin. Coliforms from birds fed salinomycin had more (P less than .05) resistance patterns involving two, five, and six drugs. Numbers of coliforms resistant to streptomycin, ampicillin, carbenicillin, and cephalothin were greater (P less than .05) from birds fed salinomycin.

Animals↗

The effect of polyether, ionophorous anticoccidial drugs on feather growth in genetically slow-feathering broilers.

The rate of feather growth was measured in Hubbard X Hubbard broilers given monensin, salinomycin, or lasalocid for 8 weeks in floor pens. Chicks were given a nutritionally adequate diet. Feathers on male chicks were shorter at 10 days of age but grew faster than those on female chicks. Male chicks had longer feathers than female chicks after 31 days of age. Back feather scores were similar in male and female chicks at 52 days of age. Dietary ionophores had no effect on the rate of feather growth or the back feather coverage under the condition of this study.

Animals↗

Effects of coccidiostats and dietary protein on performance and water consumption in broiler chickens.

Two, 7-week floor pen experiments were conducted consecutively with male broilers and then female broilers to determine the effects of feeding salinomycin (60 ppm), monensin (99 ppm), or lasalocid (125 ppm) at the following three levels of dietary protein: 1) that which meets National Research Council specifications (NRC, 1977), 2) that level deficient in sulfur amino acids (SAA), or 3) that deficient in protein. Group body weights, feed intake, and water consumption were noted at 28 and 49 days of age with feed efficiency and overall mortalities determined. Reducing SAA resulted in depressed (P less than .05) body weights at 7 weeks in both experiments, whereas deficient protein reduced (P less than .05) growth, feed efficiency, and water consumption. Generally, inclusion of coccidiostats in the diet did not significantly hinder growth or feed efficiency. Feeding of coccidiostats in combination with the low protein diet did not produce additional anorexigenic effects. Although a significant lasalocid SAA-sparing effect was not observed, diet X coccidiostat interactions (P less than .05) were apparent and attributable to an apparent "protein-sparing" effect upon body weight gain when salinomycin was fed in combination with the low protein diet. Lasalocid increased water consumption (P less than .05) relative to monensin in the female broilers.

Amino Acids, Sulfur↗